Management of patients with lower-risk myelodysplastic syndromes - Top-Institutions - MDSpire

Management of patients with lower-risk myelodysplastic syndromes

  • By

  • Andrew M. Brunner

  • Heather A. Leitch

  • Arjan A. van de Loosdrecht

  • Nicolas Bonadies

  • December 14, 2022

  • 0 min

Share

Top Institutions in Hematology

Brief introduction explaining scope and methodology.

  • #1

    Dana-Farber Cancer Institute
    Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Hematology
    • Oncology
    • Stem Cell Transplantation

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Hematology
    • Oncology
    • Molecular Diagnostics

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Hematology
    • Oncology
    • Genetics

  • #4

    Fred Hutchinson Cancer Center
    Fred Hutchinson Cancer Center

    Seattle, WA

    Key Differentiators

    • Hematology
    • Stem Cell Transplantation
    • Genomics

  • #5

    Stanford University Medical Center
    Stanford University Medical Center

    Stanford, CA

    Key Differentiators

    • Hematology
    • Oncology
    • Molecular Medicine

Original Source(s)

Management of patients with lower-risk myelodysplastic syndromes

  • by Andrew M. Brunner, Heather A. Leitch, Arjan A. van de Loosdrecht, Nicolas Bonadies

  • December 14, 2022

Related Content

Association Between Iron Deficiency and Dementia Risk: Insights from the AMORIS Population-Based Study in Sweden

Patient Resource on Vascular Disorders: Understanding Hereditary Hemorrhagic Telangiectasia (HHT)

The patients demanding unvaccinated blood transfusions